Portfolio company
PregLem
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
PregLem develops and commercialises biopharmaceutical drugs for women's reproductive health conditions, including uterine fibroids, endometriosis and infertility.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Pregnolia
Pregnolia manufactures a medical device that measures cervical stiffness for gynaecologists to assess the risk of premature birth in pregnant women.
Ardana
This company develops and markets pharmaceutical products focused on reproductive health for patients and healthcare providers.
Lumavita AG
This pharmaceutical company develops and commercialises anti-infective drugs for women's health, specifically targeting gynecological infections for patients globally.
Gesynta Pharma
This company develops anti-inflammatory and pain-relieving oral pharmaceuticals targeting the mPGES-1 enzyme for patients with endometriosis and chronic inflammatory conditions.
ReproNovo
This biopharmaceutical company develops therapeutic treatments for male and female infertility and uterine conditions for patients worldwide.
Speciality European Pharma
This company develops and distributes pharmaceutical products and medical devices for urological and gynaecological conditions to specialist physicians and hospitals across Europe.
Calla Lily Clinical Care
This company develops a leak-free vaginal drug delivery platform for women requiring fertility treatments, miscarriage management, and other gynaecological medications.
ForEndo Pharma
The company develops hormone regulation therapies for women with endometriosis and polycystic ovary syndrome.
